Page last updated: 2024-10-29

avapro and Acute Edematous Pancreatitis

avapro has been researched along with Acute Edematous Pancreatitis in 2 studies

Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.

Research Excerpts

ExcerptRelevanceReference
"To report a case of acute pancreatitis in a patient receiving a combination formulation of irbesartan and hydrochlorothiazide (HCTZ)."4.81Acute pancreatitis associated with angiotensin II receptor antagonists. ( Bassett, ML; Fisher, AA, 2002)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fisher, AA1
Bassett, ML1
Famularo, G1
Minisola, G1
Nicotra, GC1
De Simone, C1

Reviews

1 review available for avapro and Acute Edematous Pancreatitis

ArticleYear
Acute pancreatitis associated with angiotensin II receptor antagonists.
    The Annals of pharmacotherapy, 2002, Volume: 36, Issue:12

    Topics: Acute Disease; Adult; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds;

2002

Other Studies

1 other study available for avapro and Acute Edematous Pancreatitis

ArticleYear
Acute pancreatitis associated with irbesartan therapy.
    Pancreas, 2005, Volume: 31, Issue:3

    Topics: Acute Disease; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Human

2005